Vert le Petit, France

David Desailly

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Crossject. Active years: 2008.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Desailly: Innovator in Needleless Injection Technology

Introduction

David Desailly is a notable inventor based in Vert le Petit, France. He has made significant contributions to the field of medical technology, particularly with his innovative approach to injection devices. His work focuses on enhancing the efficiency and safety of drug delivery systems.

Latest Patents

Desailly holds a patent for a needleless injection device that features a mechanism for regulating gas pressure levels in the combustion chamber. This invention includes a body that supports various elements forming a circuit. The circuit consists of an initiation device linked to a pyrotechnic gas generator, a receptacle for housing a liquid active agent, and an active agent injection system. The pyrotechnic gas generator contains a pyrotechnic charge situated in a combustion chamber, and the device is characterized by its pressure regulation capabilities.

Career Highlights

David Desailly is associated with Crossject, a company that specializes in innovative drug delivery systems. His work at Crossject has positioned him as a key player in the development of advanced medical technologies. His patent reflects his commitment to improving patient care through innovative solutions.

Collaborations

Desailly has collaborated with notable colleagues, including Patrick Alexandre and Bernard Brouquieres. These partnerships have contributed to the advancement of his projects and the overall mission of Crossject.

Conclusion

David Desailly's contributions to needleless injection technology exemplify his dedication to innovation in the medical field. His patent and work at Crossject highlight the importance of developing safer and more efficient drug delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…